Frankfurt/Main – Embla Medical hf., a leading global provider of innovative mobility solutions listed on the Copenhagen Nasdaq, has signed an agreement to invest in a majority share in privately owned Streifeneder ortho.production GmbH ("Streifeneder"). Streifeneder is an internationally operating developer and supplier of orthopaedic mobility solutions. The investment in Streifeneder represents an attractive opportunity for Embla Medical to become a full range provider to a larger part of the global orthotics and prosthetics (O&P) market and strengthens Embla Medical/Össur's presence in Germany, the second largest O&P market in the world. The closing of the transaction is subject to regulatory approvals.
A CMS team led by Dr. Heike Wagner and Dr. Tobias Kilian provided Embla Medical with comprehensive legal advice on this transaction. Embla Medical is a long-standing CMS client. CMS recently advised Embla Medical on the acquisition of Fior & Gentz.
Press Contact
presse@cms-hs.com
